The estimated Net Worth of Katherine Stueland is at least $8.86 Million dollars as of 14 June 2021. Ms. Stueland owns over 20,340 units of Invitae Corp stock worth over $4,285 and over the last 8 years she sold NVTA stock worth over $5,959,935. In addition, she makes $2,891,570 as Chief Commercial Officer at Invitae Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Ms. Stueland NVTA stock SEC Form 4 insiders trading
Katherine has made over 37 trades of the Invitae Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 20,340 units of NVTA stock worth $642,744 on 14 June 2021.
The largest trade she's ever made was selling 34,300 units of Invitae Corp stock on 14 December 2020 worth over $2,004,149. On average, Katherine trades about 4,691 units every 38 days since 2017. As of 14 June 2021 she still owns at least 214,231 units of Invitae Corp stock.
You can see the complete history of Ms. Stueland stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Katherine Stueland biography
Katherine A. Stueland serves as Chief Commercial Officer of the Company. From January 2014 to October 2016, she served as our head of communications and investor relations. Prior to joining Invitae, Ms. Stueland was a Principal at Vivo Communications, a healthcare communications company, from January 2013 to December 2013. Previously, she served as Vice President, Communications and Investor Relations at Dendreon Corporation, a biotechnology company. Ms. Stueland holds a B.S in English Literature from Miami University in Ohio.
What is the salary of Katherine Stueland?
As the Chief Commercial Officer of Invitae Corp, the total compensation of Katherine Stueland at Invitae Corp is $2,891,570. There are 2 executives at Invitae Corp getting paid more, with Sean George having the highest compensation of $5,319,510.
How old is Katherine Stueland?
Katherine Stueland is 44, she's been the Chief Commercial Officer of Invitae Corp since 2016. There are 18 older and 1 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
What's Katherine Stueland's mailing address?
Katherine's mailing address filed with the SEC is C/O INVITAE CORPORATION, 1400 16TH STREET, SAN FRANCISCO, CA, 94103.
Insiders trading at Invitae Corp
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli..., and James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
What does Invitae Corp do?
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
What does Invitae Corp's logo look like?
Complete history of Ms. Stueland stock trades at Invitae Corp
Invitae Corp executives and stock owners
Invitae Corp executives and other stock owners filed with the SEC include:
-
Sean George,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Shelly Guyer,
Chief Financial Officer -
Katherine Stueland,
Chief Commercial Officer -
Robert Nussbaum,
Chief Medical Officer -
Shelly D. Guyer,
Chief Financial Officer -
Dr. Sean Emerson George Ph.D.,
Co-Founder, Pres, CEO & Director -
Lee Bendekgey,
Chief Policy Officer -
Geoffrey Crouse,
Independent Director -
Eric Aguiar,
Independent Director -
Christine Gorjanc,
Lead Independent Director -
Chitra Nayak,
Independent Director -
Jason Myers,
Director -
Kimber Lockhart,
Director -
Karthik Suri,
Chief Digital Officer -
Thomas Brida,
General Counsel, Secretary -
Robert Werner,
Chief Accounting Officer -
Kenneth Knight,
Chief Operating Officer -
Glenn Medalle,
Head of Talent -
Dr. Robert L. Nussbaum,
Chief Medical Officer -
Robert F. Werner,
Chief Accounting Officer & Principal Accounting Officer -
Desarie French,
Chief Talent Officer -
Laura D'Angelo,
Head of Investor Relations -
Yafei Wen,
Chief Financial Officer -
Layton Wedgeworth,
Chief Technology Officer -
Kenneth D. Knight,
Chief Operating Officer -
Michele Cargill Ph.D.,
Co-Founder, Key Projects & Advisor to the CEO -
Alex Furman,
Co-Founder, Culture Tsar & Head of People Analytics -
Bros. Advisors Lp Baker Bro...,
-
Bros. Advisors Lpbaker Feli...,
-
Mc Nerney & Partners Ii L.P...,
-
Lisa Alderson,
Senior VP, Marketing -
William H Osborne,
Director -
Patty Dumond,
-
Eric Thomas, Mc Nerney & Pa...,
-
James E Deerfield Mgmt L.P....,
-
E Lee Bendekgey,
Chief Operating Officer -
Randal W. Scott,
Director -
Yafei Wen,
Chief Financial Officer -
Robert M. Guigley,
Chief Commercial Officer -
David Sholehvar,
Chief Operating Officer -
Ana J. Schrank,
Chief Financial Officer